MIZU
LIVE

Serial Number

79369673

Owner

Carealytix Digital Health GmbH

Attorney

Kenneth F. Florek

Filing Date

Mar 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MIZU Trademark

Serial Number: 79369673 • Registration: 7838799

MIZU is a trademark filed by Carealytix Digital Health GmbH on March 27, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Carealytix Digital Health GmbH (3 trademarks)

Hohendilching 3

Entity Type: 99

Trademark Details

Filing Date

March 27, 2023

Registration Date

June 24, 2025

Published for Opposition

November 19, 2024

Goods & Services

[ Medical counseling; medical services; rental of equipment for human health care ]

Downloadable mobile applications * provided direct to consumer * for self-efficacy, patient empowerment and monitoring via tools, namely, medication tracking, lab and vital data documentation, remote monitoring, telemedicine, nutritional coaching, patient education, therapy documentation and patient-centered self-diagnostics for use by chronic kidney disease patients, dialysis patients, transplant recipients, patient relatives, and medical professionals, doctors, nephrologists, dialysis nurses and dialysis technicians; downloadable software * provided direct to consumer * for self-efficacy, patient empowerment and monitoring via tools, namely, medication tracking, lab and vital data documentation, remote monitoring, telemedicine, nutritional coaching, patient education, therapy documentation and patient-centered self-diagnostics for use by chronic kidney disease patients, dialysis patients, transplant recipients, patient relatives, and medical professionals, doctors, nephrologists, dialysis nurses and dialysis technicians; * all of the foregoing related specifically to chronic kidney disease *

Software development, programming and implementation; hosting services of computer websites, software as a service (SaaS) services featuring software * provided direct to consumer * for self-efficacy, patient empowerment and monitoring via tools, namely, medication tracking, lab and vital data documentation, remote monitoring, telemedicine, nutritional coaching, patient education, therapy documentation and patient-centered self-diagnostics for chronic kidney disease, dialysis patients, transplant recipients, patient relatives, and medical professionals, doctors, nephrologists, dialysis nurses and dialysis technicians, and rental of software * provided direct to consumer * for self-efficacy, patient empowerment and monitoring via tools, namely, medication tracking, lab and vital data documentation, remote monitoring, telemedicine, nutritional coaching, patient education, therapy documentation and patient-centered self-diagnostics for chronic kidney disease, dialysis patients, transplant recipients, patient relatives, and medical professionals, doctors, nephrologists, dialysis nurses and dialysis technicians; IT consultancy, advisory and information services relating to installation, maintenance and repair of computer software; * all of the foregoing related specifically to chronic kidney disease * [ medical research and pharmacological research services; clinical research for others in the field of chronic kidney disease; conducting of scientific studies for others in the field of chronic kidney disease ]

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 20, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 20, 2026 FIMP
NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED
Nov 13, 2025 NCP7
CANCELLED SEC. 7 - PARTIAL
Nov 13, 2025 C7P.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 20, 2025 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 24, 2025 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jul 25, 2025 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 24, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2025 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 29, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 18, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 2, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 16, 2024 OPNS
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 16, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 15, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 15, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 15, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 29, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 28, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 23, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 19, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 18, 2023 REPR